A fibre-optic probe which measures the amount of oxygen in tumours may help
doctors to reduce the side effects of chemotherapy. Tumours with high oxygen
levels are more susceptible to treatment, so researchers at Mount Vernon
Hospital, Middlesex, hope the probe will allow them to identify tumours which
require less chemotherapy and radiotherapy. The probe, called Oxylite, was
invented by Oxford Optronix. Its clinical development is being funded by the
Cancer Research Fund.
More from New ¾«¶«´«Ã½
Explore the latest news, articles and features
Popular articles
Trending New ¾«¶«´«Ã½ articles
1
The world's fastest spider tops 3.5 metres per second
2
Where, when and how to watch the 2026 solar eclipse
3
A type of fibre that stimulates GLP-1 release approved for use in food
4
Babies are born with the neural foundations for maths
5
The weirdness of neutrinos could completely rewrite particle physics
6
The best new science-fiction novels published in July 2026
7
We’re not the most successful human species
8
Our verdict on The Selfish Gene: An unpopular piece of popular science
9
Slowdown of AMOC ocean current may be gradual and reversible
10
Have scientists really made a living cell from scratch? Not quite
